<p>DC treated by si-Ctl (white), by si-STIM-1 (light grey) or by si-Orai-1 (dark grey) were maturated by following maturating agents (TG at 750 nM, LPS at 50 ng/ml, zymosan at 25 µg/ml or TNF-α at 20 ng/ml) for 18 h. Then, cells were harvested and quadruple staining (CD80, CD86, CD83, CD25) was assessed by FACS analysis for each condition. The results represent the mean of percentage of quadruple positive cells from 5 independent experiments (mean ± SD, *p<0,05).</p
The round THP-1 cells changed to be adherent flatten cells (white arrows). Under forward scatter and...
<p>Immature DCs were stimulated with LipESP for 48h and analysis of CD40, HLA-DR, CD86 and CD80 expr...
<p>DCs (Wistar) were treated with LPS alone or LPS plus PrA (5, 20, or 40 nM) from days 7 to 9 in vi...
<p>In panel <b>A</b>, DC were cultured in medium with maturating agents (TG (750 nM), LPS (50 ng/ml)...
<p><b>A</b>) Changes in CD86 expression on moDC after stimulation with AX alone or in combination wi...
<p>Cell surface expression of DC activation markers was determined after incubation of cells with ∼3...
<p>(<b>A</b>) Light microscopy showing control differentiated DCs (Mock, panel 1) and inhibition of ...
<p>Day-5 DCs were incubated for 2 hours with inhibitors for p72 Syk, PI3K, p38 MAPK or NF-κB after w...
<p>CCE was analyzed on DC treated by specific Orai-1 (grey line) and STIM-1 (light grey line) si-RNA...
<p>A, Effect of Orai3-knockdown on NCI-H23 cell viability (*** <i>p</i><0.001, <i>t-test</i>). B, Th...
<p><b>A</b>) Proliferation of PBMCs treated with αCD3/αCD28 in the presence of control mIgG1, αOrai1...
<p>(A) Phenotypic changes in expression of CD40, CD80 and CD86 maturation markers in TCL-loaded DCs ...
<p>In panel A, B, C, D and E, DCs were used either unstimulated (NS) or in the presence of BbC50sn (...
<p>(A) Viability assay after MVA and MVA-B infection. Viability was expressed as the percentage of l...
(A) DCs were dose-dependently treated with the indicated concentrations of MPL or BCG-CWS for 24 h. ...
The round THP-1 cells changed to be adherent flatten cells (white arrows). Under forward scatter and...
<p>Immature DCs were stimulated with LipESP for 48h and analysis of CD40, HLA-DR, CD86 and CD80 expr...
<p>DCs (Wistar) were treated with LPS alone or LPS plus PrA (5, 20, or 40 nM) from days 7 to 9 in vi...
<p>In panel <b>A</b>, DC were cultured in medium with maturating agents (TG (750 nM), LPS (50 ng/ml)...
<p><b>A</b>) Changes in CD86 expression on moDC after stimulation with AX alone or in combination wi...
<p>Cell surface expression of DC activation markers was determined after incubation of cells with ∼3...
<p>(<b>A</b>) Light microscopy showing control differentiated DCs (Mock, panel 1) and inhibition of ...
<p>Day-5 DCs were incubated for 2 hours with inhibitors for p72 Syk, PI3K, p38 MAPK or NF-κB after w...
<p>CCE was analyzed on DC treated by specific Orai-1 (grey line) and STIM-1 (light grey line) si-RNA...
<p>A, Effect of Orai3-knockdown on NCI-H23 cell viability (*** <i>p</i><0.001, <i>t-test</i>). B, Th...
<p><b>A</b>) Proliferation of PBMCs treated with αCD3/αCD28 in the presence of control mIgG1, αOrai1...
<p>(A) Phenotypic changes in expression of CD40, CD80 and CD86 maturation markers in TCL-loaded DCs ...
<p>In panel A, B, C, D and E, DCs were used either unstimulated (NS) or in the presence of BbC50sn (...
<p>(A) Viability assay after MVA and MVA-B infection. Viability was expressed as the percentage of l...
(A) DCs were dose-dependently treated with the indicated concentrations of MPL or BCG-CWS for 24 h. ...
The round THP-1 cells changed to be adherent flatten cells (white arrows). Under forward scatter and...
<p>Immature DCs were stimulated with LipESP for 48h and analysis of CD40, HLA-DR, CD86 and CD80 expr...
<p>DCs (Wistar) were treated with LPS alone or LPS plus PrA (5, 20, or 40 nM) from days 7 to 9 in vi...